- $102.61m
- $38.77m
- $52.67m
- 33
- 52
- 46
- 39
Annual income statement for Intevac, fiscal year end - December 30th, USD millions except per share, conversion factor applied.
2019 December 28th | R2021 January 2nd | 2022 December 31st | 2022 January 1st | 2023 December 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 109 | 52.1 | 35.8 | 38.5 | 52.7 |
| Cost of Revenue | |||||
| Gross Profit | 40.9 | 22.4 | 15.1 | 7.07 | 20.2 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 105 | 61 | 52.3 | 61 | 65.9 |
| Operating Profit | 3.92 | -8.88 | -16.5 | -22.5 | -13.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 4.51 | -8.72 | -15.4 | -22.5 | -10.8 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1.15 | -10.4 | -16.8 | -23.1 | -12.6 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 1.15 | 1.06 | -17.1 | 26.6 | -12.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1.15 | 1.06 | -17.1 | 26.6 | -12.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.049 | -0.456 | -0.704 | -0.949 | -0.483 |